Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|April 28, 2011
Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidismKarin Frank-Raue, Gudrun Leidig-Bruckner, Christine Haag, et al.
Plos One|December 16, 2014
Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemiaSaskia Letz, Christine Haag, Egbert Schulze, et al.
European Journal of Endocrinology|June 12, 2004
Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor geneKarin Frank-Raue, Angela Lorenz, Christine Haag, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 14, 2010
Multiple endocrine neoplasia type 2Nelson Wohllk, Heiko Schweizer, Zoran Erlic, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study)Heinrich Schmidt-Gayk, Eberhard Spanuth, Jochem Kötting, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2020
Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic MorphologyTheresa Vogel, Julia Wendler, Karin Frank-Raue, et al.
World Journal of Surgery|March 22, 2017
Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?Jerena Manoharan, Friedhelm Raue, Caroline L Lopez, et al.
Sleep|May 2, 2013
Mirtazapine provokes periodic leg movements during sleep in young healthy menStephany Fulda, Stefan Kloiber, Tatjana Dose, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2008
Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptorsRamona Rus, Christine Haag, Christiane Bumke-Vogt, et al.
Thyroid : Official Journal of the American Thyroid Association|August 13, 2020
Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid CancerViktoria F Koehler, Pia Adam, Karin Frank-Raue, et al.
Pageof 8